Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Lupien

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Nature Genetics|September 3, 2024
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactionsPeiran Su, Yin Liu, Tianyi Chen, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Nature Genetics|March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancerXin Xu, Helen Zhu, Rupert Hugh-White, et al.
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Cell|July 10, 2024
TULIPs decorate the three-dimensional genome of PFA ependymomaMichael J Johnston, John J Y Lee, Bo Hu, et al.
Nature Communications|February 13, 2021
PRMT5 inhibition disrupts splicing and stemness in glioblastomaPatty Sachamitr, Jolene C Ho, Felipe E Ciamponi, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Cell|May 24, 2020
Metabolic Regulation of the Epigenome Drives Lethal Infantile EpendymomaKulandaimanuvel Antony Michealraj, Sachin A Kumar, Leo J Y Kim, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Nature Genetics|September 3, 2024
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactionsPeiran Su, Yin Liu, Tianyi Chen, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Nature Genetics|March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancerXin Xu, Helen Zhu, Rupert Hugh-White, et al.
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Cell|July 10, 2024
TULIPs decorate the three-dimensional genome of PFA ependymomaMichael J Johnston, John J Y Lee, Bo Hu, et al.
Nature Communications|February 13, 2021
PRMT5 inhibition disrupts splicing and stemness in glioblastomaPatty Sachamitr, Jolene C Ho, Felipe E Ciamponi, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Cell|May 24, 2020
Metabolic Regulation of the Epigenome Drives Lethal Infantile EpendymomaKulandaimanuvel Antony Michealraj, Sachin A Kumar, Leo J Y Kim, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Pageof 16